Shree Ganesh Biotech (India) Ltd (NSE: SHREEGANES), ISIN INE051N01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SHREEGANES last traded at ₹0.53 (-1.85%), with a 52-week range of ₹0.52 to ₹0.82 (as of 29 Jul 2026).
Shareholding as of Dec 2025: promoters 0.00%, FIIs 1.42%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 33/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.